Trial intelligence / Profile preview

Pregabalin for Sleep Disturbance in Partial Seizures

NCT00643136Phase 3Completed

Sponsor
Pfizer
Start
Nov 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of pregabalin in sleep disorder, sponsored by Pfizer. Started Nov 2002; status: completed.

02

Drugs

pregabalin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT00643136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00643136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call